Immunocore to present at upcoming investor conferences
11 sept. 2023 17h00 HE
|
Immunocore Holdings Limited
Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 11 September 2023) Immunocore Holdings Plc (Nasdaq: IMCR), a...
Immunocore to present at upcoming investor conferences
01 sept. 2023 16h00 HE
|
Immunocore Holdings Limited
Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 01 September 2023) Immunocore Holdings Plc (Nasdaq: IMCR), a...
Immunocore Reports Second Quarter 2023 Financial Results and Provides Business Update
10 août 2023 07h00 HE
|
Immunocore Holdings Limited
Immunocore Reports Second Quarter 2023 Financial Results and Provides Business Update KIMMTRAK net revenues of £45.5 million ($57.8 million) in 2Q 2023; new launches in Italy, Austria,...
Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO
03 juin 2023 07h00 HE
|
Immunocore Holdings Limited
Early on-treatment ctDNA reduction in stable disease patients treated with KIMMTRAK was associated with longer overall survival (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md, 3...
Immunocore to present at upcoming investor conferences
01 juin 2023 16h30 HE
|
Immunocore Holdings Limited
Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 01 June 2023) Immunocore Holdings Plc (Nasdaq: IMCR), a...
Immunocore Reports First Quarter 2023 Financial Results and Provides Business Update
10 mai 2023 07h00 HE
|
Immunocore Holdings Limited
Immunocore Reports First Quarter 2023 Financial Results and Provides Business Update KIMMTRAK net revenues of £42.1 million ($52.0 million) in Q1 2023, with continued commercial expansion ...
Immunocore to present at the Bank of America Securities 2023 Health Care Conference
03 mai 2023 16h30 HE
|
Immunocore Holdings Limited
Immunocore to present at the Bank of America Securities 2023 Health Care Conference (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 03 May 2023) Immunocore Holdings Plc...
Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival
18 avr. 2023 07h00 HE
|
Immunocore Holdings Limited
Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival In the Phase 3 trial, early on-treatment ctDNA reduction was strongly associated...
Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference
11 avr. 2023 07h00 HE
|
Immunocore Holdings Limited
Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 11 April 2023) Immunocore Holdings Plc...
Immunocore to present four posters at AACR Annual Meeting 2023
14 mars 2023 16h30 HE
|
Immunocore Holdings Limited
Immunocore to present four posters at AACR Annual Meeting 2023 Updated three-year overall survival data for tebentafusp-tebn in previously treated metastatic uveal melanoma Phase 3 data showing...